Indeed, a recent study by Liu and Zhang (2019) reveals that the overexpression of miR-132 in AD upregulates CDK5 but downregulates GTDC-1, with both changes promoting the phosphorylation of tau. This evidence concerns the gene MAPT and Alzheimer disease.